AI-generated summary
The authors randomized 30 people with unilateral plantar fasciitis to 904 nm infrared laser therapy or identical placebo for 6 weeks, with 25 completing the protocol. They report reduced plantar fascia thickness and lower pain scores on a visual analogue scale in the laser group compared with placebo. The abstract describes this as a small trial.
- Participants
- 30
- Who or what was studied
- Adults with unilateral plantar fasciitis; 30 enrolled, 25 completed the therapeutic protocol
- Wavelengths
- 904 nm
- Limits stated in the abstract
- The abstract reports a small sample with 5 participants lost before completing treatment, and it does not state long-term follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 904 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Placebo-controlled, Visual analogue scale. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.